N/A
Completed N=152
Brief Cognitive Behavioral Therapy for Military Populations
Source: ClinicalTrials.gov NCT02038075 ↗Enrolled (actual)
152
Serious AEs
1.3%
Results posted
May 2016
Primary outcomePrimary: Estimated Percentage of Participants Making Suicide Attempt During 24-month Follow-up — 13.8; 40.2 estimated percentage w/ suicide attempt — p=.02
Summary
The primary purpose of this study is to compare the effectiveness of brief cognitive-behavioral therapy (B-CBT) for the treatment of suicidality, including suicidal ideation and attempts (regardless of Axis I or II diagnosis) among active duty military personnel. The standard null hypothesis will involve tests conducted comparing improvement following B-CBT (treatment duration of 12 weeks) to treatment as usual (TAU). The primary outcome comparisons will include both direct markers of suicidality (i.e. suicide, suicide attempts) and indirect markers including associated symptomatology (i.e. suicidal ideation, intent, anxiety, depression, hopelessness, substance abuse, and sleep disturbance), along with remission of psychiatric diagnoses. Secondary purposes include the prospective investigation of suicide risk factors and warning signs to explore these variables' ability to predict subsequent suicidal behavior following an index attempt.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Estimated Percentage of Participants Making Suicide Attempt During 24-month Follow-up |
13.8; 40.2 | .02 sig |
| SECONDARY Scale for Suicide Ideation (SSI) |
— | — |
| SECONDARY Beck Depression Inventory, Second Edition (BDI-II) |
— | — |
| SECONDARY Beck Hopelessness Scale (BHS) |
— | — |
| SECONDARY Beck Anxiety Inventory |
— | — |
Eligibility Criteria
Inclusion Criteria
- Active duty military
- 18 years or older
- Current suicidal ideation with intent to die and/or suicide attempt within past month
- Able to complete informed consent procedures
Exclusion Criteria
- Psychiatric or medical condition that precludes informed consent or outpatient therapy
Data sourced from ClinicalTrials.gov (NCT02038075). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.